The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported outcomes (PRO) in the GARNET trial in patients (pts) with advanced or recurrent dMMR/MSI-H endometrial cancer (EC) treated with dostarlimab.
 
Rebecca Sophie Kristeleit
Honoraria - AstraZeneca; Clovis Oncology; Merck Sharp & Dohme; Roche/Genentech; Tesaro
Consulting or Advisory Role - Basilea; Cerulean Pharma; Clovis Oncology; Roche/Genentech; Sotio
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; Valirx
 
Cara Amanda Mathews
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Seagen (Inst); Syros Pharmaceuticals (Inst); Tesaro/GSK (Inst)
 
Andres Redondo
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche; Tesaro
Research Funding - Eisai; PharmaMar; Roche
 
Joice Huang
Employment - GlaxoSmithKline K.K.
Stock and Other Ownership Interests - GlaxoSmithKline K.K.
 
Laurie Eliason
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Ellie Im
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Jubilee Brown
Honoraria - Olympus
Consulting or Advisory Role - AstraZeneca; Caris Centers of Excellence; Clovis Oncology; Genentech; Tesaro